PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Operating income, 2025
- −$158M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$158M | — |
| 2024 | $253M | — |
| 2023 | −$94M | — |
| 2022 | −$131M | — |
| 2021 | −$126M | — |
| 2020 | −$65M | — |
| 2019 | −$81M | — |
| 2018 | −$42M | — |
| 2017 | −$38M | — |
| 2016 | −$33M | — |
| 2015 | −$15M | — |
| 2014 | −$9.3M | — |